The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...

The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.

MIT researchers created a nanosensor catheter that detects bladder cancer biomarkers far earlier than current tests.

Bladder Cancer Edition Part 2 / advanced urothelial carcinoma, Andrea Necchi, Antibody drug conjugates, Astellas, bladder ...

On October 25, 2026, OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition brought together leading oncology experts ...

Perioperative treatment with durvalumab (Imfinzi) plus neoadjuvant enfortumab vedotin (EV) significantly improved event-free survival (EFS) and overall survival (OS) compared with radical cystectomy ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...

The decision gives certain patients whose cancer has resisted BCG therapy another treatment option aimed at preserving the ...

A new review explains why BCG immunotherapy fails in some bladder cancer patients and outlines emerging combination ...

A retrospective cohort of 60 patients found that bladder preservation was feasible after a complete response to neoadjuvant ...

Learn about types of incontinence pads for MS, differences between bladder and menstrual pads, skin protection tips, insurance coverage, and when to seek medical help.

A Trump administration doctor says neon yellow urine is normal because of diets consisting entirely of meat and fermented foods. Here’s what experts say ...